The Indian pharma industry has been growing rapidly, and the pharma community in the country is not only growing.
Pharmacy giants like Anupam, Sun Pharma, and Rohit Bansal are in the news for their rapid growth, and there is a growing trend in the industry to take this into the real world, as evidenced by this image.
Pharmaceutical company Anupams Pharma in Bangalore.
The image was posted on the Facebook page of its Hyderabad-based pharma company, Anupamas Pharmacy, which sells the Aveda-branded medicines.
It features a giant eagle in the middle of the Ameda logo, with the words “Pharmacist” on the top left corner, and “Pepsi” on top right.
The image has over 2,000 likes, with many commenting on it, saying that the eagle is a good representation of Anupas brand.
Pharma-wise, Anups products have a range of products from diabetes treatments to blood thinners, but Anupa has been known for its specialty in allergy medicines.
In its latest financial report, the company said that the company’s sales jumped by 8.6 per cent in the fourth quarter of 2017-18, to Rs.1,895 crore, as compared to the same quarter last year.
This is in line with the growth it saw in the last fiscal, as it has grown to Rs 8,907 crore in FY17.
It has also doubled the revenue it earned in the first quarter of this year from Rs 3,721 crore in 2016-17 to Rs 7,737 crore in 2017-19.
According to Anupama, the growth is due to the fact that the market is becoming more saturated, as more people are coming to take medicines.
“It’s very challenging for a pharma business to keep its pace,” Anupapras pharma chief executive Manish Kumar said.
“The pharma is evolving at a faster pace than ever before, and it’s important to have a variety of products to cater to different needs of the market.
This is also reflected in the growth in the company, as the total sales have been growing at an annualised rate of 15 per cent for the past three years.”
Anupams pharma sales are expected to grow at a whopping 7.5 per cent year-on-year by 2022-23.
The pharma group is also planning to expand its global reach, by taking on new opportunities in the UK, India, Singapore, the US, and Africa.
As the pharmacoins market grows, the pharmacist will be required to take on new roles and responsibilities, and be more cognizant of their business.